PROTO SCRIPT PHARMACEUTICAL CORP Selling, General and Administrative Expense
PROTO SCRIPT PHARMACEUTICAL CORP reported Selling, General and Administrative Expense of $299.23 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for the quarter ending 2017-09-30 was $299.23K, a 71.69% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for the quarter ending 2017-06-30 was $274.27K, a 92.22% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for the quarter ending 2017-03-31 was $369.07K, a 123.14% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for the quarter ending 2016-12-31 was $380.19K, a 47.01% increase year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for fiscal 2016 was $862.55K, a 2.57% increase from fiscal 2015.
- PROTO SCRIPT PHARMACEUTICAL CORP selling, general and administrative expense for fiscal 2015 was $840.98K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2017-09-30 | $299.23K 10-Q · filed 2018-03-08 | $573.50K derived: sum of 2 quarters · filed 2018-03-08 | $942.57K 10-Q · filed 2018-03-08 | $1.32M derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-06-30 | $274.27K 10-Q · filed 2018-01-17 | $643.34K 10-Q · filed 2018-01-17 | $1.02M derived: sum of 3 quarters · filed 2018-01-17 | $1.20M derived: sum of 4 quarters · filed 2018-03-08 |
| 2017-03-31 | $369.07K 10-Q · filed 2017-11-22 | $749.26K derived: sum of 2 quarters · filed 2017-11-22 | $923.54K derived: sum of 3 quarters · filed 2018-03-08 | $1.07M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-12-31 | $380.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $554.47K derived: sum of 2 quarters · filed 2018-03-08 | $697.15K derived: sum of 3 quarters · filed 2018-03-08 | $862.55K 10-K/A · filed 2017-10-19 |
| 2016-09-30 | $174.28K 10-Q · filed 2018-03-08 | $316.96K derived: sum of 2 quarters · filed 2018-03-08 | $482.37K 10-Q · filed 2018-03-08 | $740.98K derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $142.68K 10-Q · filed 2018-01-17 | $308.08K 10-Q · filed 2018-01-17 | $566.70K derived: sum of 3 quarters · filed 2018-01-17 | $740.49K derived: sum of 4 quarters · filed 2018-01-17 |
| 2016-03-31 | $165.40K 10-Q · filed 2017-11-22 | $424.01K derived: sum of 2 quarters · filed 2017-11-22 | $597.81K derived: sum of 3 quarters · filed 2017-11-22 | $791.34K derived: sum of 4 quarters · filed 2017-11-22 |
| 2015-12-31 | $258.61K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $432.40K derived: sum of 2 quarters · filed 2017-10-19 | $625.94K derived: sum of 3 quarters · filed 2017-10-19 | $840.98K 10-K/A · filed 2017-10-19 |
| 2015-09-30 | $173.79K 10-Q · filed 2017-01-06 | $367.33K derived: sum of 2 quarters · filed 2017-01-06 | $582.37K 10-Q · filed 2017-01-06 | |
| 2015-06-30 | $193.53K 10-Q · filed 2016-11-18 | $408.58K 10-Q · filed 2016-11-18 |